6505--Tacrolimus Capsules

The Department of Veterans Affairs is procuring a nationwide, indefinite‑delivery, firm‑fixed‑price contract to supply tacrolimus oral capsules (0.5 mg, 1 mg, and 5 mg) in 100‑capsule bottles for VA, DoD, IHS, BOP and State Veteran Homes. The award will be based on the lowest “price‑technically‑acceptable” proposal and will include a base year plus four one‑year options (up to five years total). The contractor must maintain FDA approvals, cGMP compliance, unique 11‑digit NDCs, bar‑coding/DSCSA serialization, and a 0.5 % cost‑recovery fee embedded in unit prices, with quarterly sales and CRF reporting. Payments will be made by the government’s pharmaceutical prime vendors rather than directly to the contractor. • Supply of three tacrolimus strengths (0.5 mg, 1 mg, 5 mg) totaling ~200 K bottles across multiple federal agencies. • Must provide unique NDC numbers, FDA ANDA/NDA references, cGMP‑validated manufacturing, and DSCSA‑compliant labeling/serialization. • Pricing must include a 0.5 % cost‑recovery fee; quarterly sales reporting required; contract includes base year plus four optional one‑year extensions.